← back to search

Edward Pequignot

Parker Institute for Cancer Immunotherapy · US
Area of research
Oncology · Public Health, Environmental and Occupational Health
Research interest
Research interests include CAR-T cell therapy research, Acute Lymphoblastic Leukemia research, Lung Cancer Diagnosis and Treatment, and Immune Cell Function and Interaction.
h-index
26
citations
6,695
works
84
NIH funding
primary concept
Medicine
email

Recent publications

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Nature Medicine 2018cited by 1,744position: middledoi
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
Cancer Discovery 2016cited by 1,076position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

No co-authors indexed yet.